The Clorox Company (NYSE:CLX) Q4 2024 Earnings Conference Call August 1, 2024 5:00 PM ET

Company Participants

Lisah Burhan - VP, IR
Linda Rendle - Chair and CEO
Kevin Jacobsen - CFO

Conference Call Participants

Filippo Falorni - Citi
Peter Grom - UBS
Andrea Teixeira - JPMorgan
Chris Carey - Wells Fargo
Bonnie Herzog - Goldman Sachs
Dara Mohsenian - Morgan Stanley
Kaumil Gajrawala - Jefferies
Kevin Grundy - BNP Paribas
Robert Moskow - TD Cowen
Olivia Tong - Raymond James
Lauren Lieberman - Barclays
Steve Powers - Deutsche Bank

Operator

Good day, ladies and gentlemen, and welcome to the Clorox Company Fourth Quarter Fiscal Year 2024 Earnings Release Conference Call. At this time, all participants are in a listen-only mode. At the conclusion of our prepared remarks, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference call, Ms. Lisah Burhan, Vice President of Investor Relations for The Clorox Company. Ms. Burhan, you may begin your conference.

Lisah Burhan

Thanks, Jen. Good afternoon and thank you for joining us. On the call today with me are Linda Rendle, our Chair CEO and Kevin Jacobsen, our CFO. I hope everyone has had a chance to review our earnings release and prepared remarks, both of these are available on our website. In just a moment, Linda will share a few opening comments and then we'll take your questions.

During this call, we may make forward-looking statements, including about our fiscal 2025 outlook. These statements are based on management's current expectations, but may differ from actual results or outcomes. In addition, we may refer to non-GAAP financial measures. Please refer to the forward-looking statements section, which identifies various factors that could affect such forward-looking statements, which has been filed with the SEC.

In addition, please refer to the non-GAAP financial information section of our earnings release and the supplemental financial schedules in the Investor Relations section of our website for reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures.

Now I'll turn it over to Linda.

Linda Rendle

Thank you for joining us today. Our fourth quarter fiscal year 2024 results reflect the continued advancement of our strategy to strengthen our competitive advantage, accelerate profitable growth and set up our company for long-term success, all while navigating a recovery from the cyber-attack earlier in the year. Thanks to the team's execution, we ended fiscal year 2024 in a position of operational strength. We fully restored supply and distribution and recovered most of the market share that we lost. We closed out with flat organic sales for the full year, despite the significant disruption caused by the cyber-attack, which drove an 18% organic sales decline in the first quarter.